ARCH Venture Fund XII, L.P.

Entity
Company
Business address
8755 W. Higgins Road, Suite 1025, 60631 Chicago, IL
Phone
773-380-6600
State of incorporation
DE
Fiscal year end
December 31
13D/G Schedule signature
ARCH Venture Fund XII, L.P. - its General Partner
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
ARCH Venture Fund XII, L.P. has filed 29 SEC EDGAR filings since 2/3/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 14, 2025 Nov 13, 2025 001-42489
SCHEDULE 13D/A Open Document Open Filing Nov 14, 2025
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Oct 29, 2025 Oct 27, 2025 001-41802
SCHEDULE 13D/A Open Document Open Filing Oct 29, 2025
SCHEDULE 13D/A Open Document Open Filing Aug 11, 2025
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Aug 1, 2025 Aug 1, 2025 001-41536
SCHEDULE 13D Open Document | Data Open Filing Feb 10, 2025
4 Open Document Open Filing 4 Feb 3, 2025 Feb 3, 2025 001-42489
3 Open Document Open Filing 3 Jan 30, 2025 Jan 30, 2025 001-42489
SC 13D/A Open Document Open Filing ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#2) Nov 22, 2024
SC 13D/A Open Document Open Filing ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D/A(#1) Nov 22, 2024
SC 13G Open Document Open Filing ARCH VENTURE FUND XII, L.P. - RAPPORT THERAPEUTICS, INC. -- SCH 13G Nov 14, 2024
4 Open Document Open Filing 4 Jun 10, 2024 Jun 10, 2024 001-42121
3 Open Document Open Filing 3 Jun 6, 2024 Jun 6, 2024 001-42121
SC 13D Open Document Open Filing ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D Feb 22, 2024
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Feb 20, 2024 Feb 15, 2024 001-41536
SC 13D/A Open Document Open Filing ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1) Dec 15, 2023
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Dec 12, 2023 Dec 8, 2023 001-41802
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 15, 2023 Nov 13, 2023 001-41802
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 13, 2023 Nov 8, 2023 001-41802
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 7, 2023 Nov 3, 2023 001-41802
SC 13D Open Document Open Filing ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D Oct 2, 2023
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 29, 2023 Sep 28, 2023 001-41802
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 27, 2023 Sep 26, 2023 001-41802
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Sep 25, 2023 Sep 22, 2023 001-41802
4 Open Document Open Filing FORM 4 SUBMISSION Sep 20, 2023 Sep 19, 2023 001-41802
3 Open Document Open Filing FORM 3 SUBMISSION Sep 14, 2023 Sep 14, 2023 001-41802
D/A Open Document Open Filing Apr 1, 2022 021-432243
D Open Document Open Filing Feb 3, 2022 021-432243